International Collaboration Aimed to Accelerate New Lubricant Product Development
News Sep 21, 2017
Image Credit: Dassault Systemes
Dassault Systèmes announced that Chevron Products Company, a division of Chevron U.S.A., and a manufacturer and supplier of premium base oils and finished lubricants, selected the 3DEXPERIENCE platform to accelerate the development of lubricant products that are sold under the Chevron, Texaco and Caltex names worldwide.
Chevron’s lubricants business has a history of innovation that includes hundreds of new or changed product projects annually. Each project involves dozens of participants across various disciplines all working on different formulations, regulations and raw materials in multiple locations. In order to maintain its leadership position in the lubricants market, Chevron sought to reduce this complexity and improve development cycles.
Dassault Systèmes’ “Perfect Product” industry solution experience responds to Chevron’s lubricants business needs. “Perfect Product,” based on the 3DEXPERIENCE platform, connects users across a company’s global operations in a digital collaborative environment to help it to reduce time, resources and costs associated with new product development.
By taking steps to achieve greater traceability of product formulations and materials, and to standardize processes for product reviews and approvals, Chevron aims to reinforce product quality across its portfolio. Using the 3DEXPERIENCE platform, multiple functions inside Chevron’s lubricants business and in different locations will be able to access a single source of searchable and reusable product data, gain insight into project status and target completion dates at any time, and enable supply chain activities.
“We turned to Dassault Systèmes to support our efforts to build on more than a century of scientific lubricants research and innovation,” said Brian Stripling, General Manager, Brand, Technology and OEM, Chevron Lubricants. “We aligned our processes and work based on best business practices and functionality thanks to the services of Tech Mahindra, Dassault Systèmes’ systems integration partner. As we continue this journey to reduce complexity, we have embarked on integrating additional processes into our Dassault Systèmes platform.”
"Dassault Systèmes’ 3DEXPERIENCE platform enabled us to rapidly iterate with business stakeholders in delivering digital transformation of product development processes,” said Ashim Guha, Vice President Consulting & Enterprise Solutions, Tech Mahindra. “The customer was able to transition from legacy Lotus Notes apps to the new platform in less than a year and on budget.”
“Oil and gas - like most of the energy, process and utilities sector - has complex processes which can cause issues that are discovered too late in the product development process and delay the delivery of solutions to market,” said Thomas Grand, Vice President, Energy, Process and Utilities Industry, Dassault Systèmes. “The 3DEXPERIENCE platform helps accelerate new product introduction by offering stakeholders across the value chain easy and real-time access to relevant information about the products they are working on. This opens opportunities for companies like Chevron to benefit from an enterprise-wide approach to innovation that the 3DEXPERIENCE platform makes possible.”
This article has been republished from materials provided by Dassault Systemes. Note: material may have been edited for length and content. For further information, please contact the cited source.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.READ MORE